10-Q: Quarterly report
RW: Registration Withdrawal Request
TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Sire Group Ltd.(14.1%),Seow Gim Shen(14.1%)
TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 3: Initial statement of beneficial ownership of securities-Director Mokhtar Firdauz
TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 3: Initial statement of beneficial ownership of securities-Director Flores Francisco
TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 8-K: Current report
TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 10-K: Annual report
TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 8-K: Current report
No Data